REVLIMID
-
Antitrust litigation against Dr Reddy’s Laboratories, Celgene and Bristol-Myers Squibb in US
The complaint has asked for equitable redress and damages for alleged over payments An antitrust lawsuit was filed in the…
Read More » -
Cipla announces settlement of REVLIMID capsules patent litigation
Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited amounts…
Read More »